We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $22.7B
This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.7B
AUM Growth
+$2.27B
Cap. Flow
-$358M
Cap. Flow %
-1.58%
Top 10 Hldgs %
27.07%
Holding
1,590
New
113
Increased
536
Reduced
704
Closed
103

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$205M
2
PANW icon
Palo Alto Networks
PANW
+$43.8M
3
HON icon
Honeywell
HON
+$41.6M
4
MRVL icon
Marvell Technology
MRVL
+$39.1M
5
ORCL icon
Oracle
ORCL
+$26.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.48%
2 Technology 23.07%
3 Financials 9.4%
4 Healthcare 8.74%
5 Consumer Discretionary 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQT icon
351
EQT Corp
EQT
$34.2B
$10.3M 0.05%
194,657
+154,468
+384% +$8.67M
IWO icon
352
iShares Russell 2000 Growth ETF
IWO
$14.4B
$10.2M 0.05%
25,920
-1,397
-5% -$510K
MDLZ icon
353
Mondelez International
MDLZ
$79.7B
$10.2M 0.05%
176,138
-35,110
-17% -$2.12M
GD icon
354
General Dynamics
GD
$95.4B
$10.2M 0.04%
28,738
-387
-1% -$133K
IVW icon
355
iShares S&P 500 Growth ETF
IVW
$76.5B
$10.1M 0.04%
73,444
+11,479
+19% +$1.52M
UHS icon
356
Universal Health Services
UHS
$10.4B
$10.1M 0.04%
67,627
+54,931
+433% +$8.93M
EFOR
357
Everforth Inc
EFOR
$1.25B
$9.93M 0.04%
555,440
+345,632
+165% +$8.44M
SAP icon
358
SAP
SAP
$241B
$9.92M 0.04%
64,388
-3,319
-5% -$566K
CNX icon
359
CNX Resources
CNX
$5.44B
$9.89M 0.04%
291,404
-12,145
-4% -$438K
SUPN icon
360
Supernus Pharmaceuticals
SUPN
$2.45B
$9.81M 0.04%
210,952
-8,147
-4% -$391K
OMCL icon
361
Omnicell
OMCL
$1.53B
$9.75M 0.04%
+234,771
New +$9.46M
PBH icon
362
Prestige Consumer Healthcare
PBH
$2.31B
$9.73M 0.04%
205,818
-6,643
-3% -$341K
LCII icon
363
LCI Industries
LCII
$2.33B
$9.59M 0.04%
90,590
-3,908
-4% -$430K
ATI icon
364
ATI
ATI
$28.1B
$9.52M 0.04%
+48,299
New +$8.19M
DOW icon
365
Dow Inc
DOW
$21.2B
$9.51M 0.04%
347,650
-4,396
-1% -$160K
RNR icon
366
RenaissanceRe
RNR
$13.4B
$9.4M 0.04%
29,651
+1,737
+6% +$522K
ACWI icon
367
iShares MSCI ACWI ETF
ACWI
$33.1B
$9.36M 0.04%
59,653
-1,233
-2% -$188K
SHOP icon
368
Shopify
SHOP
$163B
$9.3M 0.04%
81,421
-33,947
-29% -$3.87M
CDNS icon
369
Cadence Design Systems
CDNS
$78.4B
$9.28M 0.04%
24,723
-2,343
-9% -$821K
NVS icon
370
Novartis
NVS
$261B
$9.27M 0.04%
59,156
-3,910
-6% -$586K
BA icon
371
Boeing
BA
$163B
$9.25M 0.04%
42,724
+2,807
+7% +$625K
CCL icon
372
Carnival Corporation Ltd
CCL
$31.1B
$9.23M 0.04%
322,963
+277,135
+605% +$7.57M
PANW icon
373
Palo Alto Networks
PANW
$273B
$9.1M 0.04%
26,688
-191,298
-88% -$43.8M
XLE icon
374
State Street Energy Select Sector SPDR ETF
XLE
$43B
$9.09M 0.04%
171,152
+2,583
+2% +$148K
EFV icon
375
iShares MSCI EAFE Value ETF
EFV
$31.7B
$9.01M 0.04%
117,649
+1,813
+2% +$140K

Similar funds

Glenmede Trust's Q2 2026 Portfolio in Review

As of Q2 2026, Glenmede Trust held 1,590 positions worth $22.7B, up 11% from $20.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Glenmede Trust's Q2 2026 filing shows 113 new, 536 increased, 704 reduced and 103 closed positions. Its largest new stake was Honeywell Aerospace: 175,141 shares worth $38.7M. The largest sale was RTX Corp, an estimated $205M.

By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

  • Glenmede Trust's largest Q2 2026 buy was Honeywell Aerospace: 175,141 shares worth $38.7M.
  • Glenmede Trust added most to iShares Core MSCI International Developed Markets ETF in Q2 2026, an estimated $142M increase.
  • Glenmede Trust's biggest Q2 2026 reduction was Palo Alto Networks, cutting an estimated $43.8M.
  • Glenmede Trust fully exited RTX Corp in Q2 2026, selling an estimated $205M.
  • Glenmede Trust's ten largest holdings make up 27% of its $22.7B portfolio in Q2 2026.
  • Glenmede Trust opened 113 new positions and closed 103 in Q2 2026.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $22.7B.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.